Can You Prescribe Ozempic for Weight Loss?

Last reviewed: June 4, 2026

Last updated: June 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Ozempic is FDA-approved exclusively for type 2 diabetes management, not weight loss. However, the active ingredient semaglutide has become the cornerstone of personalized weight loss therapy when prescribed by licensed providers through compounded formulations. PlexusDx connects patients with this evidence-based option through licensed 503A compounding pharmacies, starting at just $189 per month.

Why Ozempic Isn't Labeled for Weight Loss

The FDA approved Ozempic (semaglutide injection) in 2017 specifically for improving blood sugar control in adults with type 2 diabetes. Its weight loss benefit emerged as a secondary observation during clinical trials, where patients experienced significant appetite suppression and reduced caloric intake. Because the original indication was diabetes, not obesity, the brand-name Ozempic carries no weight loss label.

Novo Nordisk developed a separate product called Wegovy with the identical semaglutide molecule, dosed specifically for weight loss and FDA-approved in 2021. However, Wegovy's cost ($969–$1,550 per month for brand-name) and supply constraints have driven many patients toward compounded alternatives. PlexusDx sources semaglutide from licensed 503A compounding pharmacies, delivering the same active compound at significantly lower cost without requiring insurance.

How Semaglutide Works for Weight Loss

Semaglutide is a GLP-1 receptor agonist—a synthetic hormone that mimics glucagon-like peptide-1, which regulates appetite and blood sugar naturally. When injected, it slows gastric emptying, making meals feel more satisfying longer, and signals the brain's satiety centers that you've eaten enough. Clinical trials show patients on semaglutide consume 500–800 fewer calories daily without intentional restriction.

The weight loss effect isn't instantaneous. Most patients experience gradual appetite reduction over 4–8 weeks, with maximum benefit achieved at higher doses over 16–20 weeks of titration. PlexusDx's approach personalizes this journey: your dose may need to go up over time to maintain effectiveness, but your price remains flat at $189 per month.

Off-Label Prescribing and Legal Considerations

Once an FDA-approved medication exists, prescribers can legally use it for conditions beyond its original label—a practice called off-label prescribing. Semaglutide for weight loss represents standard off-label practice supported by robust clinical evidence and adopted by major medical societies. Your provider assumes responsibility for ensuring the off-label use is medically appropriate for your specific health profile.

The distinction matters: compounded semaglutide is not FDA-approved as a weight loss drug, but it contains an FDA-approved active ingredient manufactured under strict quality standards. PlexusDx partners exclusively with licensed 503A compounding pharmacies, which operate under pharmaceutical compounding regulations and are subject to state board oversight. This ensures medication safety equivalent to brand-name products at a fraction of the cost.

PlexusDx Semaglutide: Cost, Access, and Genetic Personalization

PlexusDx Compounded Semaglutide Injection is $189/mo month-to-month (or $149/mo on the 6-month plan)—a 70–85% reduction versus brand-name Wegovy. No insurance is required, no membership fees apply, and the medication is HSA/FSA eligible. PlexusDx serves all 50 states and handles the entire process: online consultation, prescription coordination, and direct pharmacy shipping to your door.

For patients seeking deeper insight into their metabolic response, PlexusDx offers the Precision Peptide Genetic Test ($298). This test examines 14 metabolic pathways and 49 peptides, including key variants in which influences how effectively your body responds to semaglutide. This personalization helps your provider optimize dosing and medication selection before committing to long-term therapy.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Is it legal for my doctor to prescribe Ozempic or semaglutide for weight loss?

Yes. Once FDA-approved, medications can be prescribed off-label for other conditions based on clinical evidence. Semaglutide for weight loss is standard off-label practice supported by major medical organizations. Your provider must determine it's medically appropriate for you.

What's the difference between Ozempic, Wegovy, and compounded semaglutide?

All three contain identical semaglutide molecules. Ozempic is labeled for diabetes, Wegovy for weight loss, and compounded semaglutide is the same active ingredient manufactured by licensed pharmacies. The clinical effect is equivalent, but compounded options cost significantly less.

How quickly will I lose weight on semaglutide?

Weight loss typically becomes noticeable after 4–8 weeks as appetite suppression increases. Most significant results occur over 16–20 weeks of dose escalation. Clinical trials show average weight loss of 15–22% of body weight over one year at therapeutic doses.

How much does PlexusDx semaglutide cost compared to brand names?

PlexusDx Compounded Semaglutide Injection is $189/mo month-to-month (or $149/mo on the 6-month plan)—versus $969–$1,550 monthly for Wegovy. Your dose may increase over time, but your price stays flat. No insurance, membership fees, or hidden costs apply.

What is the Precision Peptide Genetic Test and should I get it?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Is compounded semaglutide as safe as brand-name Wegovy?

PlexusDx sources semaglutide exclusively from licensed 503A compounding pharmacies, which operate under strict pharmaceutical regulations and state board oversight. The active ingredient and manufacturing standards are equivalent to brand-name products.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Weight Loss Drugs Like Ozempic
• Ozempic Weight Loss Before And After Pictures

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.